Creatinine Quantitative Testing Drug - Vietnam Registration 230002151/PCBB-HN
Access comprehensive regulatory information for Creatinine Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi B medical device is registered under number 230002151/PCBB-HN and manufactured by Abbott Ireland Diagnostics Division.
This page provides complete technical specifications, regulatory compliance details, 4 companies making similar products including Ortho-Clinical Diagnostics Inc., Roche Diagnostics (Suzhou) Ltd., and 4 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Technical Details
Creatinine2 testing is performed to quantify creatinine in human serum, plasma, or urine on the ARCHITECT c Systems. Creatinine2 testing is used to support the diagnosis and treatment of kidney diseases, to monitor dialysis, and as a basis for calculation when measuring other analytes in urine.
Dates and Status
Aug 31, 2023
Creatinine Quantitative Testing Drug
Roche Diagnostics (Suzhou) Ltd.
240000442/PCBB-HCM
Creatinine Quantitative Testing Drug
FUJIFILM Wako Pure Chemical Corporation
240000301/PCBB-HN
Creatinine Quantitative Testing Drug
Abbott Ireland Diagnostics Division
230002152/PCBB-HN
Creatinine Quantitative Testing Drug
Ortho-Clinical Diagnostics Inc.
230000148/PCBB-BYT